Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae.
about
Characterization of a distinct host response profile to Pneumocystis murina asci during clearance of pneumocystis pneumoniaRecent advances in the management of mucormycosis: from bench to bedsideEchinocandin treatment of pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the infectionDynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatmentCharacterization of Scedosporium apiospermum glucosylceramides and their involvement in fungal development and macrophage functionsInnate immunity to Aspergillus species.Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection.Aspergillus galactosaminogalactan mediates adherence to host constituents and conceals hyphal β-glucan from the immune system.Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.PrtT-regulated proteins secreted by Aspergillus fumigatus activate MAPK signaling in exposed A549 lung cells leading to necrotic cell death.Fungal infections in transplant and oncology patients.Endoplasmic reticulum localized PerA is required for cell wall integrity, azole drug resistance, and virulence in Aspergillus fumigatus.Breakthrough invasive candidiasis in patients on micafungin.Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents.The Aspergillus fumigatus cspA gene encoding a repeat-rich cell wall protein is important for normal conidial cell wall architecture and interaction with host cellsDL-2-hydroxyisocaproic acid attenuates inflammatory responses in a murine Candida albicans biofilm model.Dectin-1: a role in antifungal defense and consequences of genetic polymorphisms in humans.Protective effects of surfactant protein D treatment in 1,3-β-glucan-modulated allergic inflammation.Micafungin in the treatment of invasive candidiasis and invasive aspergillosisCandida albicans infections in renal transplant recipients: effect of caspofungin on polymorphonuclear cellsDifferences in efficacy and cytokine profiles following echinocandin or liposomal amphotericin B monotherapy or combination therapy for murine pulmonary or systemic Aspergillus flavus infectionsFuture directions in mucormycosis research.Role of innate immune receptors in paradoxical caspofungin activity in vivo in preclinical aspergillosis.Micafungin Elicits an Immunomodulatory Effect in Galleria mellonella and Mice.Invasive fungal infections in acute leukemia.Albumin Enhances Caspofungin Activity against Aspergillus Species by Facilitating Drug Delivery to Germinating Hyphae.Nanoscopic cell-wall architecture of an immunogenic ligand in Candida albicans during antifungal drug treatment.Hypoxia enhances innate immune activation to Aspergillus fumigatus through cell wall modulation.Stage-specific innate immune recognition of Aspergillus fumigatus and modulation by echinocandin drugs.Impact of in vivo triazole and echinocandin combination therapy for invasive pulmonary aspergillosis: enhanced efficacy against Cyp51 mutant isolatesDeletion of the α-(1,3)-glucan synthase genes induces a restructuring of the conidial cell wall responsible for the avirulence of Aspergillus fumigatus.Impaired bactericidal but not fungicidal activity of polymorphonuclear neutrophils in patients with chronic lymphocytic leukemia.Pattern recognition: recent insights from Dectin-1Aspergillus fumigatus: cell wall polysaccharides, their biosynthesis and organization.Immunotherapy for opportunistic infections: Current status and future perspectives.Current perspectives on echinocandin class drugs.Invasive fungal infections in the ICU.Echinocandin pharmacodynamics: review and clinical implications.Use of posaconazole in the treatment of invasive fungal infections.Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic stem cell transplant recipients.
P2860
Q24614334-5BE65BF8-EDE9-45C3-9221-7438725B3D94Q24642450-95C27BE7-5F5F-444B-A00D-7A1C3C198179Q28472713-9548FA96-0965-419C-A307-411F6945FCBAQ28474181-9AFEAEC9-1B78-4ADC-96C9-5F51A4843EB3Q28539197-E87FBE00-281F-483E-83F3-13FCCE6AB660Q30434628-9EA57F34-7CEB-48D7-BF48-CDB7C002AB56Q30585324-AAC3C714-7894-4645-A22B-E650DABAA811Q31129835-20751EE0-F6B8-4EA3-91A0-49134DD52BE4Q33490772-4D1F1ECC-3AFE-4124-A3F8-C32F6E17FF5BQ33848942-D493E274-CBAF-49F3-8559-8130A20DBA0FQ33896940-840EBAF3-F3D5-42D5-BF3F-BA59A4BEFAAAQ33956119-175D8118-5591-400A-97AA-84360703EA87Q33963538-D17B8C62-A9CE-4E70-A35F-3CB3EDCF6656Q34024546-A7FD93EE-68C1-46B9-8515-56FB7F084DD9Q34118934-093E249F-B61B-4E66-B0D8-F16C3631431BQ34260729-6B19D774-23C3-4854-89E1-9159D17607C9Q34520982-43C1717E-3A30-4F2A-ADC9-1F0B5087F041Q34673568-DB135F6E-1F3A-4D38-8BDC-A368F2E3F9EDQ35026516-1D25A0D9-F42F-49F9-8AD1-013619C8540DQ35598563-2EC2F45A-68AE-4217-A87F-7255636EC158Q35666612-C47CCDE3-1E05-436A-9097-B8C03644BEE4Q35672102-30EEBB3C-CB54-42A3-9246-EC92B7600A1CQ36171611-B9FC8860-EEDE-4E0D-9ED0-66AFFE8AB3E0Q36365889-8EA37D57-4BDD-4085-BB2E-701ECD8E1366Q36612597-DFCB9698-10B7-40C4-9D3C-7CBA6C8A93FCQ36644611-AF84908B-9521-4D5A-A10C-5D54735212F0Q36685105-E3FD22E8-E2E6-4633-9127-02C0EBAC81A9Q37045301-E80AED7B-827D-459B-8E9D-1847833C1EC9Q37209970-ABFF0497-ECBC-4D3F-9619-8BC294918029Q37263430-0C71868C-9B78-4A2C-95A4-E25D056736B0Q37308743-B36828A4-BFDD-45CC-B453-24D8790B3A57Q37382813-FB4D913A-8AF6-43D9-9403-468146411728Q37395165-C3ECED60-0E07-4218-99C0-6CF5A2BD27AAQ37506518-F8766CF6-7595-4FC6-8800-129016B2F210Q37509216-2B5CA353-1D06-484A-80A7-E874E1F55E8FQ37554055-B6724833-C43D-4D67-9DA9-8BBD2540786AQ37643057-4940282F-DADE-453D-94AA-701B15172035Q37718385-94D9FA2B-8A83-4E7A-8700-88F83A8D5392Q37810083-26BF3336-3377-4752-9003-B49A54E81CC0Q37816399-8FABB521-B335-4FB2-9A8A-320F6EC4FF56
P2860
Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Caspofungin-mediated beta-gluc ...... us and non-Aspergillus hyphae.
@en
Caspofungin-mediated beta-gluc ...... us and non-Aspergillus hyphae.
@nl
type
label
Caspofungin-mediated beta-gluc ...... us and non-Aspergillus hyphae.
@en
Caspofungin-mediated beta-gluc ...... us and non-Aspergillus hyphae.
@nl
prefLabel
Caspofungin-mediated beta-gluc ...... us and non-Aspergillus hyphae.
@en
Caspofungin-mediated beta-gluc ...... us and non-Aspergillus hyphae.
@nl
P2093
P2860
P356
P1476
Caspofungin-mediated beta-gluc ...... us and non-Aspergillus hyphae.
@en
P2093
Amar Safdar
Dimitrios P Kontoyiannis
Georgios Chamilos
Gregory A Lamaris
Gregory S May
Issam I Raad
Thomas J Walsh
P2860
P304
P356
10.1086/589305
P407
P577
2008-07-01T00:00:00Z